Home / Inspections / 1223617

FDA Inspection 1223617 — Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC

Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC — FEI 1222181

The FDA completed an inspection of Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC on October 13, 2023 in Andover, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 13, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Andover, MA (United States)

Facility

Other inspections at this facility

  • 1311392 (VAI Wed Apr 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1304580 (NAI Wed Feb 11 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1218069 (VAI Tue Sep 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1020234 (VAI Fri Apr 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 988784 (VAI Fri Sep 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources